Top Story

European Commission approves adalimumab biosimilar for treatment of RA, PsA, AS, JIA

March 27, 2017

The European Commission has approved Amgevita, a biosimilar to adalimumab, for the treatment of moderate to severe rheumatoid arthritis, psoriatic arthritis, severe active ankylosing spondylitis, severe axial spondyloarthritis without radiographic evidence of ankylosing spondylitis in addition to moderate to severe chronic plaque psoriasis, moderate-to-severe hidradenitis suppurativa, non-infectious intermediate, posterior and panuveitis, moderate to severe Crohn’s disease and moderate to severe ulcerative colitis. It is also approved for Crohn’s disease in children aged 6 years and older, severe chronic plaque psoriasis in children aged 4 years and older, enthesitis-related arthritis in children aged 6 years and older and polyarticular juvenile idiopathic arthritis in children aged 2 years and older.

“The approval of our first biosimilar by the European Commission is a major milestone not just for Amgen as a company, but for the millions of patients with chronic inflammatory diseases who need alternative treatment options,” Sean E. Harper, MD, executive vice president of Research and Development at Amgen, said. “In addition, Amgevita holds the potential to offer patients with chronic inflammatory diseases an additional treatment option. This milestone exemplifies our ongoing dedication to the development of high-quality biologic medicines.”

In the Journals

AAP offers strategies to address needs of children in kinship families

March 27, 2017
The AAP recently issued a policy statement offering guidelines and strategies for pediatricians to address the unique needs of children living with nonparental family

WHO releases ethics guidance to protect rights of patients with TB

March 27, 2017
WHO recently issued new tuberculosis ethics guidance that outlines key obligations for countries that implement the End TB Strategy to protect patients’ rights. …
In the JournalsPerspective

Adolescent e-cigarette use may not lead to combustible cigarette use

March 27, 2017
Previously published data suggesting that people, especially teenagers, who use electronic cigarettes are more likely to start smoking combustible cigarettes may not be…

NIH investigates single vaccine to protect against several mosquito-borne viruses

March 27, 2017
With mosquito-borne illnesses posing an ongoing public health threat around the world, there is a significant need for advances in combating and controlling mosquito…
More News Headlines »
CME Article

When Memories Become Malignant: An Update on Posttraumatic Stress Disorder in Children and Adolescents

Psychiatric Annals, March 2017, Volume 47 Issue 3
Children and adolescents are susceptible to developing posttraumatic stress disorder (PTSD), which has serious…
More »

Unusual Diagnoses: Part 2: March 2015

Keck School of Medicine of USC and Pediatric Annals

It was once said that the task of the generalist is the most difficult of all. “In a sea of normal children, the…
More »
American Academy of Allergy, Asthma & Immunology Annual Meeting

American Academy of Allergy, Asthma & Immunology Annual Meeting

Meeting News

VIDEO: How a physician can perform well in MIPS

March 23, 2017
More »